A new study highlights the Cardio-Ankle Vascular Index (CAVI) as a powerful tool for predicting COPD progression and outcomes ...

The US Food and Drug Administration (FDA) has approved mepolizumab as a maintenance treatment for chronic obstructive ...

GSK has gained approval from the US Food and Drug Administration (FDA) for its monoclonal antibody, Nucala (mepolizumab), as ...

New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of ...

A BMJ Open Respiratory Research study finds women aged over 40 face a 50% higher risk of developing COPD than men—even non-smokers. Indoor pollutants (cooking fumes, cleaning sprays), occupational ...

Both AATD and COPD are conditions that can lead to breathing ... Ph.D., lead researcher and senior author on the paper. "Our test provides an accurate, comprehensive and rapid genotyping solution ...

Incorporating chest CT imaging and respiratory symptoms into the chronic obstructive pulmonary disease (COPD) diagnostic ...

Current recommendations for diagnosis of COPD in patients with respiratory symptoms require detection of airflow obstruction ...

The GOLD classification is used to determine COPD severity and help form a treatment plan. This is based on the spirometry test result of your FEV1. This is the amount of air you can breathe out ...

Former smokers with COPD reporting higher perceived stress had poorer scores on respiratory health assessments, according to ...

"In fact, women had a nearly identical increase in risk of COPD for every 10 pack-years of cigarette use when compared with ...

London: GSK plc has received approval from the US Food and Drug Administration (FDA) for Nucala (mepolizumab) as an add-on ...